Antiretroviral Recommendations May Influence the Rate of Transmission of Drug‐Resistant HIV Type 1
Author(s) -
Carmen de Mendoza,
Carmen Rodríguez,
José Marı́a Eiros Bouza,
Javier Colomina,
Féderico García,
Pilar Suarez Leiva,
José Miguel Cisneros,
Jesús Agüero,
J. Pedreira,
Isabel Viciana,
Angélica Corral,
Jorge del Romero,
Raúl Ortíz de Lejarazu,
Vincent Soriano
Publication year - 2005
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/431203
Subject(s) - medicine , transmission (telecommunications) , human immunodeficiency virus (hiv) , virology , antiretroviral drug , drug , drug resistance , virus , sida , lentivirus , viral disease , antiretroviral therapy , intensive care medicine , viral load , pharmacology , biology , microbiology and biotechnology , electrical engineering , engineering
Human immunodeficiency virus (HIV) treatment guidelines have evolved, shifting from more-aggressive to more-conservative approaches. The potential impact of these shifts on the transmission of drug-resistant virus is unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom